AVITA Medical, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $70.9M | $63.9M | $50.1M | $34.4M | — |
| Gross profit | $58.8M | $55.2M | $42.4M | $28.4M | — |
| Operating income | -$42.5M | -$56.6M | -$42.7M | -$27.5M | — |
| Operating expenses | $101.3M | $111.8M | $86.4M | $59.1M | — |
| Cost of revenue | $12.8M | $9.1M | $7.8M | $6.0M | — |
| Cash from operations | -$31.2M | -$48.9M | -$38.0M | -$19.1M | — |
| Capital expenditure | $1.0M | $9.2M | $1.4M | $452,000 | — |
| Free cash flow | -$32.2M | -$58.1M | -$39.4M | -$19.5M | — |
| Impairments | $0 | $0 | $0 | $0 | — |
| Total assets | $56.4M | $79.7M | $111.6M | $98.3M | $116.0M |
| Total liabilities | $73.0M | $75.0M | $61.9M | $13.0M | $11.4M |
| Total debt | $40.0M | $40.0M | — | — | — |
Shares outstanding 30.8M · Free float 97.8%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.